These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11886466)

  • 21. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience.
    DiMichele DM; Gorman PO; Kasper CK; Mannucci PM; Santagostino E; Hay CR
    Haemophilia; 2002 Jan; 8 Suppl 1():9-12; discussion 28-32. PubMed ID: 11882076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.
    Parra Lopez R; Nemes L; Jimenez-Yuste V; Rusen L; Cid AR; Charnigo RJ; Baumann JA; Smith L; Korth-Bradley JM; Rendo P
    Thromb Haemost; 2015 Oct; 114(4):676-84. PubMed ID: 26293201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance.
    Taher A; Abiad R; Uthman I
    Lupus; 2003; 12(11):854-6. PubMed ID: 14667103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia.
    Taparia M; Cordingley FT; Leahy MF
    Eur J Haematol; 2002 May; 68(5):307-9. PubMed ID: 12144537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acquired haemophilia due to autoantibodies against factor VIII].
    von Depka Prondzinski M
    Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM; Franchini M
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint bleeds increase the inhibitor response to human factor VIII in a rat model of severe haemophilia A.
    Lövgren KM; Søndergaard H; Skov S; Wiinberg B
    Haemophilia; 2016 Sep; 22(5):772-9. PubMed ID: 27439658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VIII antibody in a patient with mild haemophilia.
    Bovill EG; Burns SL; Golden EA
    Br J Haematol; 1985 Oct; 61(2):323-8. PubMed ID: 3929830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired haemophilia and rheumatoid arthritis.
    Soriano RM; Matthews JM; Guerado-Parra E
    Br J Rheumatol; 1987 Oct; 26(5):381-3. PubMed ID: 3117157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of porcine factor VIII in the management of unexpected bleeding episodes.
    Aledort LM
    Haemophilia; 2002 Jan; 8 Suppl 1():17-9; discussion 28-32. PubMed ID: 11882078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
    Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitor eradication in refractory acquired hemophilia with lenalidomide.
    Pfrepper C; Poenisch W; Pierer M; Metze M; Kaiser T; Petros S
    Ann Hematol; 2019 Jun; 98(6):1533-1535. PubMed ID: 30706086
    [No Abstract]   [Full Text] [Related]  

  • 35. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porcine factor VIII: current status and future developments.
    Hay CR
    Haemophilia; 2002 Jan; 8 Suppl 1():24-7; discussion 28-32. PubMed ID: 11882080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII.
    Leebeek FW; Kappers-Klunne MC; Jie KS
    Haemophilia; 2004 May; 10(3):250-3. PubMed ID: 15086322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bullous pemphigoid and acquired haemophilia].
    Kluger N; Navarro R; Pallure V; Guillot B
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired haemophilia - a study of ten cases.
    Saxena R; Mishra DK; Kashyap R; Choudhry VP; Mahapatra M; Bhargava M
    Haemophilia; 2000 Mar; 6(2):78-83. PubMed ID: 10781192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.